Chiesi  凯西  
凯西集团1935年成立于意大利帕尔马市，2012年集团销售额为11.07亿欧元，比上一年增长了4.7%。集团主要致力于呼吸系统疾病和特殊治疗领域，在全球拥有25家分公司，药品销往60多个国家。药品生产地在帕尔马市、法国的Blois和巴西的Santana de Parnaiba。2012年研发投入为1.98亿欧元，为销售额的17.8%，同时公司计划未来的研发投入将保持在该水平。帕尔马市的研究中心与位于巴黎、美国Rockville和英国Chippenham的实验室紧密合作，共同推进集团的临床前、临床阶段和注册阶段的研发项目。截至2012年底凯西集团拥有3800多名员工，其中440多名员工专业从事研发工作。

Founded in 1935 in Parma, Italy, Chiesi Farmaceutici currently has 25 affiliates worldwide and markets its therapeutics in over 60 countries. Chiesi's manufacturing plants in Parma, Blois (France) and Santana de Parnaiba (Brazil), and R&D centers in Parma, Paris, Rockville (USA) and Chippenham (UK) integrate their efforts to advance the Group's pre-clinical, clinical and registration programs. At the end of 2012, the Chiesi Group's total staff stood at over 3,800 people, more than 350 of whom are dedicated to R&D. The main areas of activity are in respiratory therapeutics and specialist medicine areas.